ibogaine has been researched along with spiradoline in 2 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (spiradoline) | Trials (spiradoline) | Recent Studies (post-2010) (spiradoline) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 132 | 6 | 24 |
| Protein | Taxonomy | ibogaine (IC50) | spiradoline (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.234 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashim, A; Lajtha, A; Sershen, H | 2 |
2 other study(ies) available for ibogaine and spiradoline
| Article | Year |
|---|---|
The effect of ibogaine on kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6By mice.
Topics: Animals; Biguanides; Cocaine; Corpus Striatum; Dopamine; Electric Stimulation; Ibogaine; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Serotonin | 1995 |
Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release.
Topics: Animals; Behavior, Animal; Cocaine; Corpus Striatum; Culture Techniques; Dopamine; Drug Administration Schedule; Female; Ibogaine; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Perfusion; Pyrrolidines; Receptors, Opioid, kappa; Sex Factors | 1998 |